Programme Scope

What this test series covers

Drug formulation, Biopharmaceutics, Pharmacokinetics, Drug stability — fundamental pharmaceutical sciences applied within Singapore pharmacy practice.

Therapeutics across major disease states, Drug interactions, Adverse drug reactions, Clinical monitoring — highest-weight PLE clinical domain.

Medicines Act (Cap 176), Poisons Act, HSA drug scheduling (POM/P/OTC/Pharmacy-Only), Controlled drugs, Singapore Pharmacy Board Code of Ethics.

Medication counselling, Adherence support, OTC advisory, Patient safety goals, Cross-cultural communication in Singapore's multiracial context.

Singapore HSA adverse drug reporting, High-alert medications, ISMP recommendations, Quality use of medicines in Singapore healthcare settings.

Learning Objectives

What this test series achieves

To assess PLE readiness across all Singapore pharmacy competency domains through timed mock examinations aligned to the Singapore Pharmacy Board PLE framework

To develop Singapore pharmacy law knowledge — Medicines Act, Poisons Act, HSA drug scheduling, Controlled drug handling under Singapore regulations

To master clinical pharmacology MCQs — drug therapy management, ADR monitoring, and drug interactions within Singapore's multiracial patient context

To build PLE examination pacing strategy — completing all MCQs confidently within the allotted time across all pharmacy domains

To identify domain performance gaps using AURA analytics calibrated to the Singapore Pharmacy Board PLE competency framework

To track readiness with a real-time PLE Pass Probability Score updated after every session

To reinforce Singapore Medicines Act and HSA scheduling MCQs — distinctly different from overseas pharmacy law training backgrounds

To benchmark PLE performance against a global candidate cohort and understand readiness relative to the Singapore Pharmacy Board passing standard

Target Audience

Who can enrol

Programme Certification

Your certificate